Submit Deal

ROSEMONT PHARMACEUTICALS

Summary

Rosemont Pharmaceuticals is a drug manufacturing company.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 156 M

Avg. Deal Size£ 156 M

Market Context

Senior Management

Howard Taylor
CEO

Sort

rothschild & co

HQ - Paris

financial advisors (1)

1 Shared Deal

1 Opposite

£ 156 M

Total Value

trowers & hamlins

legal advisors (1)

1 Shared Deal

1 Opposite

£ 156 M

Total Value

grant thornton

HQ - London, United Kingdom

accounting advisors (1)

1 Shared Deal

1 Opposite

£ 156 M

Total Value

deloitte

HQ - London

financial advisors (1)

1 Shared Deal

1 Opposite

£ 156 M

Total Value

citigate dewe rogerson

HQ - London

pr advisors (1)

1 Shared Deal

1 Opposite

£ 156 M

Total Value

travers smith

HQ - London

legal advisors (1)

1 Shared Deal

1 Opposite

£ 156 M

Total Value

macfarlanes

HQ - London

legal advisors (1)

1 Shared Deal

1 Along

£ 156 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy